Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
VRCA
$4.80
+7.51%
VRCA
· Verrica Pharmaceuticals Inc.
$4.80
+0.34 (+7.51%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$75.07M
Shares
17.18M
Volume · Sep 30
50.99K
Avg daily vol (3M)
62.01K
All earnings calls
Earnings call · FY2020 Q2
Verrica Pharmaceuticals Inc. (VRCA) Q2 2020 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Net income
-$9.41M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 14, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2020 · complete as-filed document